Literature DB >> 21812661

The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model.

Sami Uwaydat1, Purushottam Jha, Ruslana Tytarenko, Harry Brown, Michael Wiggins, Puran S Bora, Nalini S Bora.   

Abstract

PURPOSE: To investigate the effect of topically applied honey on intact corneas, surgically induced corneal abrasions and endotoxin induced keratitis.
MATERIALS AND METHODS: The effect of honey on the cornea was investigated by application of honey on intact corneas, wounded corneas and endotoxin-induced keratitis in Lewis rats. The corneas were wounded by creating an epithelial defect using a surgical blade, and the keratitis was induced by topically applying Pseudomonas aeruginosa endotoxin to scarified corneas. After treatment rats were sacrificed and cornea harvested in each case. Corneas were processed for paraffin embedding for histological and immuno-fluorescence staining. Corneas were also harvested and processed for total ribonucleic acid (RNA) isolation for reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for various growth factors and inflammatory chemokines/cytokines).
RESULTS: Histological analysis revealed that no inflammation or morphological changes occurred after honey treatment in naive intact corneas. Vascular endothelial growth factor (VEGF) levels were also not altered after honey treatment. Topical application of honey to injured corneas resulted in faster epithelial healing and decreased expression of VEGF, transforming growth factor beta (TGF-β), interferon gamma (IFN-γ), interleukin 12 (IL-12) and tumor necrosis factor alpha (TNF-α) in injured corneas. Our results also established that honey treatment reduced the inflammation in endotoxin-induced keratitis by reducing the levels of angiogenic factors (VEGF and TGF-β), inflammatory cytokines (IL-12) and chemokines (CC chemokine receptor 5(CCR-5)).
CONCLUSION: Short term use of honey on intact corneas can be safe. Honey has anti-angiogenic and anti-inflammatory properties that can be explored in several corneal inflammatory and infectious conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812661     DOI: 10.3109/02713683.2010.544441

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

Review 1.  Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review.

Authors:  Anna Francis; Yeoungjee Cho; David W Johnson
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-17       Impact factor: 2.629

2.  Use of complementary and alternative therapies by patients with eye diseases: a hospital-based cross-sectional study from Palestine.

Authors:  Dania Jaber; Rafat Abu Ghannam; Waleed Rashed; Mohammad Shehadeh; Sa'ed H Zyoud
Journal:  BMC Complement Med Ther       Date:  2021-01-04

3.  Treatment of Corneal Alkali Burn with Chestnut Honey, Royal Jelly, and Chestnut Honey-Royal Jelly Mixture.

Authors:  Kursat Atalay; Kubra Serefoglu Cabuk; Ahmet Kirgiz; Aysel Kara Caglar
Journal:  Beyoglu Eye J       Date:  2019-12-27

4.  Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.

Authors:  Li Wen; Meidong Zhu; Michele C Madigan; Jingjing You; Nicholas J C King; Francis A Billson; Kathryn McClellan; Gerard Sutton; Con Petsoglou
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

5.  Tualang honey improves human corneal epithelial progenitor cell migration and cellular resistance to oxidative stress in vitro.

Authors:  Jun Jie Tan; Siti Maisura Azmi; Yoke Keong Yong; Hong Leong Cheah; Vuanghao Lim; Doblin Sandai; Bakiah Shaharuddin
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.